A detailed history of Black Rock Inc. transactions in Volitionrx LTD stock. As of the latest transaction made, Black Rock Inc. holds 516,073 shares of VNRX stock, worth $356,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares
516,073
Previous 573,760 10.05%
Holding current value
$356,090
Previous $436,000 27.98%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.59 - $0.91 $34,035 - $52,495
-57,687 Reduced 10.05%
516,073 $314,000
Q1 2024

May 10, 2024

SELL
$0.72 - $1.19 $2,278 - $3,765
-3,164 Reduced 0.55%
573,760 $436,000
Q4 2023

Feb 13, 2024

BUY
$0.55 - $0.88 $13,387 - $21,420
24,341 Added 4.4%
576,924 $415,000
Q3 2023

Nov 13, 2023

SELL
$0.69 - $1.53 $10,655 - $23,627
-15,443 Reduced 2.72%
552,583 $381,000
Q2 2023

Aug 11, 2023

BUY
$1.39 - $2.02 $28,103 - $40,840
20,218 Added 3.69%
568,026 $789,000
Q1 2023

May 12, 2023

BUY
$1.54 - $2.68 $10,336 - $17,988
6,712 Added 1.24%
547,808 $1.05 Million
Q4 2022

Feb 13, 2023

BUY
$1.39 - $2.6 $4,388 - $8,208
3,157 Added 0.59%
541,096 $1.31 Million
Q3 2022

Nov 14, 2022

SELL
$1.36 - $2.38 $3,504 - $6,133
-2,577 Reduced 0.48%
537,939 $732,000
Q2 2022

Aug 12, 2022

SELL
$1.96 - $3.05 $14,398 - $22,405
-7,346 Reduced 1.34%
540,516 $1.11 Million
Q1 2022

May 12, 2022

BUY
$2.41 - $3.24 $13,602 - $18,286
5,644 Added 1.04%
547,862 $1.65 Million
Q4 2021

Feb 10, 2022

BUY
$3.02 - $4.13 $14,698 - $20,100
4,867 Added 0.91%
542,218 $1.7 Million
Q3 2021

Nov 09, 2021

SELL
$2.98 - $3.48 $42,700 - $49,864
-14,329 Reduced 2.6%
537,351 $1.67 Million
Q2 2021

Aug 11, 2021

BUY
$3.01 - $3.78 $1.66 Million - $2.09 Million
551,680 New
551,680 $1.82 Million

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $39.5M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.